Healthcare -
Biotechnology - NASDAQ - US
$ 4.84
1.26 %
$ 288 M
Market Cap
-6.45
P/E
ALDX - CASH & EQUIVALENTS
Cash & Equivalents ALDX - Aldeyra Therapeutics, Inc.
143 M
LAST VALUE
-21.16%
2 YEAR CAGR
24.70%
5 YEAR CAGR
45.92%
10 YEAR CAGR